UNM Researchers Study the use of psychedelic-assisted therapy for treatment for post-partum depression (PPD)
The University of New Mexico’s Psychedelic-Assisted Therapy Research team is partnering with Reunion Neuroscience to evaluate a form of psychedelic assisted therapy for treating postpartum depression.
The Reconnect study is a Phase 2, Multicenter, Randomized, Double-Blind, Parallel-Group, Active Dose-Controlled study. In addition to a single dose of treatment, participants will also receive a preparation session before the dose and two integration sessions post dose.
Those who believe they may meet the study criteria of having had childbirth within the last 12 months and meet diagnostic criteria for post-partum depression may confidentially send their contact information through this link and will be contacted by a member of the research team.
Larry Leeman, MD, MPH
A note of gratitude: The psychedelic assisted therapy approach used by our UNM team has been guided by trainings and mentorship from the California Institute of Integral Studies (CIIS), Psychedelic Research and Training Institute (PRATI), Polaris Insight Center, and the Multidisciplinary Association for Psychedelic Studies (MAPS). We are thankful for their guidance. We extend our homage and gratitude to the indigenous peoples who were the originators and holders of the sacred medicine traditions that inform this work today.
Related Links
RE104—A Novel, Shorter- Acting Psychedelic for Postpartum Depression